The Carcinogenesis Bioassay in Perspective: Application in Identifying Human Cancer Hazards

Overview

Journal Environ Health Perspect

Date 1995 Jul 1

PMID 7588478

Citations 17

Authors

V A Fung

J C Barrett

J Huff

Affiliations

Soon will be listed here.

Abstract

The selection process for chemicals tested in the rodent carcinogenicity bioassay has been biased toward chemicals suspected of potential carcinogenicity. Results from carcinogenicity bioassays of 400 chemicals tested by the National Cancer Institute/National Toxicology Program (NCI/NTP) were analyzed to determine the dependence of positive results on chemical selection criteria: those suspected of being carcinogenic and those selected based on large volumes produced and widespread exposures. Of these chemicals, 210 (52%) induced carcinogenicity in at least one organ of one sex of one species of the four sex/species groups typically used by NCI/NTP. Only 92 of the 400 chemicals (23%) were positive in two species and thus by international criteria are considered likely to pose a carcinogenic hazard to humans. A total of 267 chemicals (67%) were selected as suspect carcinogens, and 187 (68%) of these were carcinogenic. Suspect chemicals account for 86% of chemicals with at least one positive result and account for 90% of chemicals considered positive in two species. The International Agency for Research on Cancer (IARC) lists only 5 of the 400 chemicals as carcinogenic to humans (group 1) and 10 as probably carcinogenic to humans (group 2A). The majority (80%) of the 133 chemicals selected only on production/exposure considerations were not carcinogenic in animals, even when tested at the maximum tolerated (or minimally toxic) dose. Only 9 (6.8%) were positive in two species, and none is listed in IARC groups 1 or 2A. Thus, on the basis of our analyses we predict that less than 5-10% of the 75,000 chemicals in commercial use might be reasonably anticipated to be carcinogenic to humans.

Citing Articles

DCAMCP: A deep learning model based on capsule network and attention mechanism for molecular carcinogenicity prediction.

Chen Z, Zhang L, Sun J, Meng R, Yin S, Zhao Q J Cell Mol Med. 2023; 27(20):3117-3126.

PMID: 37525507 PMC: 10568665. DOI: 10.1111/jcmm.17889.

CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods.

Zhang L, Ai H, Chen W, Yin Z, Hu H, Zhu J Sci Rep. 2017; 7(1):2118.

PMID: 28522849 PMC: 5437031. DOI: 10.1038/s41598-017-02365-0.

Animal Models of Chemical Carcinogenesis: Driving Breakthroughs in Cancer Research for 100 Years.

Kemp C Cold Spring Harb Protoc. 2015; 2015(10):865-74.

PMID: 26430259 PMC: 4949043. DOI: 10.1101/pdb.top069906.

Power, expertise and the limits of representative democracy: genetics as scientific progress or political legitimation in carcinogenic risk assessment of pharmaceuticals?.

Abraham J, Ballinger R J Community Genet. 2011; 3(2):91-103.

PMID: 22109906 PMC: 3312948. DOI: 10.1007/s12687-011-0060-2.

Genetic toxicology in the 21st century: reflections and future directions.

Mahadevan B, Snyder R, Waters M, Benz R, Kemper R, Tice R Environ Mol Mutagen. 2011; 52(5):339-54.

PMID: 21538556 PMC: 3160238. DOI: 10.1002/em.20653.

References

Huff J, McConnell E, Haseman J, Boorman G, Eustis S, Schwetz B . Carcinogenesis studies: results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program. Ann N Y Acad Sci. 1988; 534:1-30. DOI: 10.1111/j.1749-6632.1988.tb30085.x. View

Bertram J, Kolonel L, Meyskens Jr F . Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 1987; 47(11):3012-31. View

Tennant R, Spalding J, Stasiewicz S, Ashby J . Prediction of the outcome of rodent carcinogenicity bioassays currently being conducted on 44 chemicals by the National Toxicology Program. Mutagenesis. 1990; 5(1):3-14. DOI: 10.1093/mutage/5.1.3. View

Boyd J, Barrett J . Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther. 1990; 46(3):469-86. DOI: 10.1016/0163-7258(90)90028-z. View

Ames B, Gold L . Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990; 249(4972):970-1. DOI: 10.1126/science.2136249. View

Chhabra R, Huff J, Schwetz B, Selkirk J . An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ Health Perspect. 1990; 86:313-21. PMC: 1567743. DOI: 10.1289/ehp.9086313. View

Preston-Martin S, Pike M, Ross R, Jones P, Henderson B . Increased cell division as a cause of human cancer. Cancer Res. 1990; 50(23):7415-21. View

Weinstein I . Mitogenesis is only one factor in carcinogenesis. Science. 1991; 251(4992):387-8. DOI: 10.1126/science.1989073. View

Huff J, Haseman J, Rall D . Scientific concepts, value, and significance of chemical carcinogenesis studies. Annu Rev Pharmacol Toxicol. 1991; 31:621-52. DOI: 10.1146/annurev.pa.31.040191.003201. View

10.

Huff J . Design strategies, results and evaluations of long-term chemical carcinogenesis studies. Scand J Work Environ Health. 1992; 18 Suppl 1:31-7. View

11.

Huff J, Hoel D . Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992; 18 Suppl 1:83-9. View

12.

Tennant R . Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutat Res. 1993; 286(1):111-8. DOI: 10.1016/0027-5107(93)90006-2. View

13.

Huff J . Issues and controversies surrounding qualitative strategies for identifying and forecasting cancer causing agents in the human environment. Pharmacol Toxicol. 1993; 72 Suppl 1:12-27. DOI: 10.1111/j.1600-0773.1993.tb01664.x. View

14.

Melnick R, Huff J, Barrett J, Maronpot R, Lucier G, Portier C . Cell proliferation and chemical carcinogenesis: a symposium overview. Mol Carcinog. 1993; 7(3):135-8. DOI: 10.1002/mc.2940070302. View

15.

Lijinsky W . Species differences in carcinogenesis. In Vivo. 1993; 7(1):65-72. View

16.

Fung V, Huff J, WEISBURGER E, Hoel D . Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam Appl Toxicol. 1993; 20(4):413-36. DOI: 10.1006/faat.1993.1053. View

17.

Huff J . Chemicals and cancer in humans: first evidence in experimental animals. Environ Health Perspect. 1993; 100:201-10. PMC: 1519590. DOI: 10.1289/ehp.93100201. View

18.

Barrett J . Mechanisms of multistep carcinogenesis and carcinogen risk assessment. Environ Health Perspect. 1993; 100:9-20. PMC: 1519586. DOI: 10.1289/ehp.931009. View

19.

Melnick R, Huff J . Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation. Toxicol Ind Health. 1993; 9(3):415-38. DOI: 10.1177/074823379300900303. View

20.

Wachsman J, Bristol D, Spalding J, Shelby M, Tennant R . Predicting chemical carcinogenesis in rodents. Environ Health Perspect. 1993; 101(5):444-5. PMC: 1519826. DOI: 10.1289/ehp.93101444. View